"Therapeutic approaches to multiple sclerosis: Initiating remyelination and immunomodulation using estrogen receptor β ligands," by Seema Kaushalya Tiwari-Woodruff, PhD, Professor, Division of Biomedical Sciences, Director, Graduate Program in Biomedical Sciences, Co-Director Block 9, Medical School Education, School of Medicine, University of California Riverside
- Event Type
- Seminar/Symposium
- Sponsor
- Neuroscience Program
- Location
- Beckman Institute 1005
- Date
- Nov 7, 2023 4:00 pm
- Views
- 105
An unmet need in Multiple sclerosis (MS) is the discovery of a functional remyelinating therapy. In the current seminar identification of novel estrogen receptor ligands (UIUC collaboration) that are immunomodulatory and induce functional remyelination in different mouse models of MS will be discussed.